Aripiprazole
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
59651-515 -
Package NDC
59651-515-03 -
Package NDC
59651-515-30 -
Application number
ANDA216208 -
SPL ID
da73c5ab-4841-4081-8fdf-adc2ea343dcb -
SPL set ID
476b92f3-cf7b-4c09-ac67-6ed35e6811d5 -
UNII
82VFR53I78 -
RxCUI
643019 -
RxCUI
643022
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- Aripiprazole
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Aripiprazole",
"splId": "da73c5ab-4841-4081-8fdf-adc2ea343dcb",
"labels": [
{
"setId": "476b92f3-cf7b-4c09-ac67-6ed35e6811d5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=476b92f3-cf7b-4c09-ac67-6ed35e6811d5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=476b92f3-cf7b-4c09-ac67-6ed35e6811d5"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (59651-515-03) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
"package_ndc": "59651-515-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20260218"
},
{
"sample": false,
"description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-515-30)",
"package_ndc": "59651-515-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20260218"
}
],
"productId": "59651-515_da73c5ab-4841-4081-8fdf-adc2ea343dcb",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "59651-515",
"deaSchedule": null,
"genericName": "Aripiprazole",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ARIPIPRAZOLE",
"strength": "15 mg/1"
}
],
"applicationNumber": "ANDA216208",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260218",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175430"
],
"unii": [
"82VFR53I78"
],
"rxcui": [
"643019",
"643022"
],
"spl_set_id": [
"476b92f3-cf7b-4c09-ac67-6ed35e6811d5"
],
"pharm_class_epc": [
"Atypical Antipsychotic [EPC]"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:59651-515_da73c5ab-4841-4081-8fdf-adc2ea343dcb"